Summit Therapeutics Inc. Common Stock
Symbol: SMMT (NASDAQ)
19.29
▲ (3.68%) 0.685
Company Description:
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Key Stats
- Today's Open: $19.36
- Today's High: $19.64
- Today's Low: $19.285
- Today's Volume: 68.17K
- Yesterday Close: $18.6
- Yesterday High: $18.75
- Yesterday Low: $17.77
- Yesterday Volume: 6.12M
- Last Min Volume: 170
- Last Min High: $19.367
- Last Min Low: $19.285
- Last Min VWAP: $19.34909
Company Profile
- Name: Summit Therapeutics Inc. Common Stock
- Website: https://www.smmttx.com
- Listed Date: 2015-03-05
- Location: MIAMI, FL
- Market Status: Active
- CIK Number: 0001599298
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $13.08B
- Round Lot: 100
- Outstanding Shares: 742.85M
- Asset Type: CS
RECENT FILINGS FOR SMMT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-08 | 8-K | View |
| 2025-08-11 | 8-K | View |
| 2025-08-11 | 8-K | View |
| 2025-08-11 | 424B5 | View |
| 2025-08-11 | 10-Q | View |
| 2025-06-20 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-05-30 | 8-K | View |
| 2025-05-19 | S-8 | View |
| 2025-05-01 | 4 | View |
| 2025-05-01 | 4 | View |
| 2025-05-01 | 4 | View |
| 2025-05-01 | 4 | View |
| 2025-05-01 | 10-Q | View |
| 2025-05-01 | 8-K | View |
| 2025-04-29 | ARS | View |
Latest News on SMMT